LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States.

    Braunstein, Lior Z / Gillespie, Erin F / Hong, Linda / Xu, Amy / Bakhoum, Samuel F / Cuaron, John / Mueller, Boris / McCormick, Beryl / Cahlon, Oren / Powell, Simon / Khan, Atif J

    Advances in radiation oncology

    2020  Volume 5, Issue 4, Page(s) 582–588

    Abstract: ... guidelines for omitting or abbreviating breast cancer radiation therapy, where appropriate, in an effort ... resources and place patients at risk of infection, the parsimonious application of breast radiation therapy ... breast cancer experts at a high-volume comprehensive cancer center convened contingency planning meetings ...

    Abstract Purpose: Breast radiation therapy accounts for a significant proportion of patient volume in contemporary radiation oncology practice. In the setting of anticipated resource constraints and widespread community infection with SARS-CoV-2 during the COVID-19 pandemic, measures for balancing both infectious and oncologic risk among patients and providers must be carefully considered. Here, we present evidence-based guidelines for omitting or abbreviating breast cancer radiation therapy, where appropriate, in an effort to mitigate risk to patients and optimize resource utilization.
    Methods and materials: Multidisciplinary breast cancer experts at a high-volume comprehensive cancer center convened contingency planning meetings over the early days of the COVID-19 pandemic to review the relevant literature and establish recommendations for the application of hypofractionated and abbreviated breast radiation regimens.
    Results: Substantial evidence exists to support omitting radiation among certain favorable risk subgroups of patients with breast cancer and for abbreviating or accelerating regimens among others. For those who require either whole-breast or postmastectomy radiation, with or without coverage of the regional lymph nodes, a growing body of literature supports various hypofractionated approaches that appear safe and effective.
    Conclusions: In the setting of a public health emergency with the potential to strain critical healthcare resources and place patients at risk of infection, the parsimonious application of breast radiation therapy may alleviate a significant clinical burden without compromising long-term oncologic outcomes. The judicious and personalized use of immature study data may be warranted in the setting of a competing mortality risk from this widespread pandemic.
    Keywords covid19
    Language English
    Publishing date 2020-04-01
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2452-1094
    ISSN 2452-1094
    DOI 10.1016/j.adro.2020.03.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Breast Radiation Therapy Under COVID-19 Pandemic Resource ConstraintsApproaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States

    Braunstein, Lior Z. / Gillespie, Erin F. / Hong, Linda / Xu, Amy / Bakhoum, Samuel F. / Cuaron, John / Mueller, Boris / McCormick, Beryl / Cahlon, Oren / Powell, Simon / Khan, Atif J.

    Advances in Radiation Oncology

    2020  Volume 5, Issue 4, Page(s) 582–588

    Keywords Oncology ; Radiology Nuclear Medicine and imaging ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ISSN 2452-1094
    DOI 10.1016/j.adro.2020.03.013
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article: Breast radiotherapy under COVID-19 pandemic resource constraints -- approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States

    Braunstein, Lior Z / Gillespie, Erin F / Hong, Linda / Xu, Amy / Bakhoum, Samuel F / Cuaron, John / Mueller, Boris / McCormick, Beryl / Cahlon, Oren / Powell, Simon / Khan, Atif J

    Abstract: ... exists to support omitting radiation among certain favorable risk subgroups of breast cancer patients and ... guidelines for omitting or abbreviating breast cancer radiotherapy, where appropriate, in an effort ... in contemporary radiation oncology practice. In the setting of anticipated resource constraints and widespread ...

    Abstract Introduction: Breast radiotherapy accounts for a significant proportion of patient volume in contemporary radiation oncology practice. In the setting of anticipated resource constraints and widespread community infection with SARS-CoV-2 during the COVID-19 pandemic, measures for balancing both infectious and oncologic risk among patients and providers must be carefully considered. Here, we present evidence-based guidelines for omitting or abbreviating breast cancer radiotherapy, where appropriate, in an effort to mitigate risk to patients and optimize resource utilization. Methods: Multidisciplinary breast cancer experts at a high-volume comprehensive cancer center convened contingency planning meetings over the early days of the COVID-19 pandemic to review the relevant literature and establish recommendations for the application of hypofractionated and abbreviated breast radiation regimens. Results: Substantial evidence exists to support omitting radiation among certain favorable risk subgroups of breast cancer patients and for abbreviating or accelerating regimens among others. For those who require either whole-breast or post-mastectomy radiation, with or without coverage of the regional lymph nodes, a growing body of literature supports various hypofractionated approaches that appear safe and effective. Conclusion: In the setting of a public health emergency with the potential to strain critical healthcare resources and place patients at infection risk, the parsimonious application of breast radiotherapy may alleviate a significant clinical burden without compromising long term oncologic outcomes. The judicious and personalized use of immature study data may be warranted in the setting of a competing mortality risk from this widespread pandemic.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #208963
    Database COVID19

    Kategorien

To top